We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Duration of Anti-PD-1 Therapy in Metastatic Melanoma (STOP-GAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02821013
Recruitment Status : Recruiting
First Posted : July 1, 2016
Last Update Posted : January 6, 2022
Sponsor:
Collaborator:
Melanoma and Skin Cancer Trials Limited
Information provided by (Responsible Party):
Canadian Cancer Trials Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2027
Estimated Study Completion Date : December 31, 2029